NASDAQ:CYNO Cynosure (CYNO) Stock Price, News & Analysis → This Little-Known Stock Controls the Future of AI (From Weiss Ratings) (Ad) Free CYNO Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Share Share Today's Range$66.00▼$66.0050-Day Range N/A52-Week Range$39.90▼$66.65VolumeN/AAverage Volume1.24 million shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Cynosure alerts: Email Address Ad Weiss RatingsThis Little-Known Stock Controls the Future of AI#1 AI Stock for 2024 Revealed In "AI Town Hall" This AI company just signed a deal with NVIDIA that went unreported by the media. Find out how you can get in on what is being dubbed 'the #1 AI stock for 2024 to buy now'If You Missed Out On The AI Boom, Take These 3 Steps About Cynosure Stock (NASDAQ:CYNO)Cynosure, Inc. develops, manufactures and markets aesthetic treatment systems that enable plastic surgeons, dermatologists and other medical practitioners to perform non-invasive and minimally invasive procedures to remove hair, treat vascular and benign pigmented lesions, remove multi-colored tattoos, revitalize the skin, reduce fat through laser lipolysis, reduce cellulite, clear nails infected by toe fungus, ablate sweat glands and improve women's health. The Company also markets radiofrequency (RF), energy-sourced medical devices for surgical applications, such as facial plastic and general surgery, gynecology, ear, nose, and throat procedures, ophthalmology, oral and maxillofacial surgery, podiatry and proctology. The Company sells its products globally under the Cynosure, Palomar, ConBio and Ellman brand names. Its product portfolio includes single energy source systems, as well as workstations that incorporate two or more different types of lasers or light-based technologies.Read More Ad Weiss RatingsThis Little-Known Stock Controls the Future of AI#1 AI Stock for 2024 Revealed In "AI Town Hall" This AI company just signed a deal with NVIDIA that went unreported by the media. Find out how you can get in on what is being dubbed 'the #1 AI stock for 2024 to buy now'If You Missed Out On The AI Boom, Take These 3 Steps CYNO Stock News HeadlinesApril 18, 2024 | msn.comA new look at the original Romanic heartthrob, Lord ByronApril 17, 2024 | msn.comI Tried RF Microneedling: Here’s What You Need to KnowApril 18, 2024 | Weiss Ratings (Ad)Nvidia Has a BIG Problem — Here’s Who Benefits MOST#1 AI Stock for 2024 Revealed In "AI Town Hall" This AI company just signed a deal with NVIDIA that went unreported by the media. Find out how you can get in on what is being dubbed 'the #1 AI stock for 2024 to buy now'April 14, 2024 | msn.comEscaping summer in Karimnagar’s serene sightsApril 13, 2024 | msn.comMS Dhoni touches World Cup trophy in emotional reunion after 13 years ahead of MI vs CSK IPL matchApril 12, 2024 | msn.comNIMASA in Blue Economy: Tinubu's brainchild-ministry promoting Nigeria's bilateral relationsApril 12, 2024 | msn.com“Wasn’t Worth”: Tony Khan’s Low Dynamite Ratings Brutally Mocked Online After CM Punk All In Footage Idea Falls FlatApril 12, 2024 | msn.comIs growth the new value? Top fund manager’s take on investing, portfolio must-haves at all-time highsApril 18, 2024 | Weiss Ratings (Ad)Nvidia Has a BIG Problem — Here’s Who Benefits MOST#1 AI Stock for 2024 Revealed In "AI Town Hall" This AI company just signed a deal with NVIDIA that went unreported by the media. Find out how you can get in on what is being dubbed 'the #1 AI stock for 2024 to buy now'April 9, 2024 | msn.com'Sanju Samson can open for India...': Gill, Jaiswal's fresh challenge as Lara, Rayudu name 'definite T20WC frontrunners'April 8, 2024 | msn.comPreserving the legacy of chess in KolkataApril 7, 2024 | msn.comIPL 2024: Would GT be able to capitalise Mayank`s pace?April 6, 2024 | msn.comDC vs MI Dream11 Predictions: Delhi Capitals vs Mumbai Indians Playing 11 Updates & Fantasy Picks DetailsApril 6, 2024 | msn.comIPL 2024: Fit-again Suryakumar expected to rescue struggling MIApril 6, 2024 | msn.comChristian Coleman Would Never Have Become the Fastest Man if Not for This AmbitionApril 4, 2024 | msn.comAbiola Makinde lays foundation for movie village in OndoApril 4, 2024 | msn.comPraggnanandhaa to meet Firouza in the opener; Gukesh to clash with ViditApril 3, 2024 | markets.businessinsider.comReveal Lasers Reports First Quarter With Record-Breaking 300% GrowthApril 3, 2024 | msn.comGST surge in Odisha exceeds budget estimate by over Rs 1,300 croreApril 2, 2024 | finance.yahoo.comHahn & Company Begins Strategic Merger of Cynosure and LutronicApril 1, 2024 | msn.comPriyanka Chopra enjoys rain after returning to Los Angeles: 'My favourite sounds'March 30, 2024 | msn.comNNL commends team’s performance in 2024 State Federation CupMarch 30, 2024 | msn.comIn St Moritz: 4 minutes in a minus 110 degree sauna, Swiss wine and ski lessonsMarch 29, 2024 | msn.comEnhanced Games: Olympic Medalist James Magnussen’s $1 Million Doping Deal Faces Backlash From Swimming LegendMarch 28, 2024 | msn.comSpice of Life: Reel to real, realising unsung hero withinMarch 28, 2024 | msn.comTwo highly educated candidates lock horns for Visakhapatnam Lok Sabha seatMarch 26, 2024 | msn.comPics: Priyanka Chopra-Nick Jonas, daughter Malti and family celebrate Holi 2024See More Headlines Receive CYNO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cynosure and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings7/26/2016Today4/18/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorN/A Industry N/A Sub-IndustryHealth Care Equipment Current SymbolNASDAQ:CYNO CUSIP23257720 CIK885306 Webwww.cynosure.com Phone+1-978-2564200FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report CYNO Stock Analysis - Frequently Asked Questions How were Cynosure's earnings last quarter? Cynosure, Inc. (NASDAQ:CYNO) issued its quarterly earnings data on Tuesday, July, 26th. The medical equipment provider reported $0.36 earnings per share for the quarter, topping the consensus estimate of $0.29 by $0.07. The medical equipment provider earned $110.30 million during the quarter, compared to the consensus estimate of $101.31 million. The business's revenue for the quarter was up 31.8% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.30 EPS. What other stocks do shareholders of Cynosure own? Based on aggregate information from My MarketBeat watchlists, some companies that other Cynosure investors own include Global Blood Therapeutics (GBT), Hawkins (HWKN), DHT (DHT), NVIDIA (NVDA), Xtrackers California Municipal Bond ETF (CA), Golar LNG Partners (GMLP), Micron Technology (MU), Endologix (ELGX), BlackRock (BLK) and Chipotle Mexican Grill (CMG). This page (NASDAQ:CYNO) was last updated on 4/18/2024 by MarketBeat.com Staff From Our Partners[Urgent!] Generational Wealth GameplanCrypto 101 MediaThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingBiden’s $374B Giveaway Into This SectorDTIForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressHe Is Giving Away BitcoinCrypto Swap ProfitsThe Next Nvidia?InvestorPlaceHow Biden has already won 2024Porter & CompanyOptions trading has suddenly become more reliable.Eagle Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cynosure, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.